Intersect ENT Announces FDA Approval of Additional Indication for PROPEL® Mini Sinus Implant PROPEL Mini Now Indicated to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—March 23, 2016—Intersect ENT, In

First Page		Document Content
Date: 2016-03-23 16:11:00 Medical equipment Medical technology Propel mometasone furoate implant RTT Sinus implant Sinusitis Intersect ENT Sinus Otorhinolaryngology Paranasal sinuses Frontal sinus Balloon sinuplasty		Intersect ENT Announces FDA Approval of Additional Indication for PROPEL® Mini Sinus Implant PROPEL Mini Now Indicated to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—March 23, 2016—Intersect ENT, In Add to Reading List Source URL: propelopens.com Download Document from Source Website File Size: 32,53 KB Share Document on Facebook

	Órgão Científico Oficial da Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (Brazilian Association of Otorhinolaryngology and Cervicofacial Surgery) Associação Brasileira de Otorrinolaring DocID: 1uPSh - View Document
	Authors’ agreement \| Brazilian Journal of Otorhinolaryngology Manuscript Number: Manuscript Title: Corresponding author: Name, Email, address, phone DocID: 1uMU7 - View Document
	Generalised additive mixed modelling for dynamic formant analysis Márton Sóskuthy, University of York A common strategy in acoustic studies of vocalic sounds is to take formant measurements at a single point for each t DocID: 1rs0W - View Document
	The Australasian College of Cosmetic Surgery Raising Standards, Protecting Patients MEDIA RELEASE For immediate release DocID: 1rqNA - View Document
	CURRICULUM VITAE DATE PREPARED: October 05, 2011 PART I: General Information Name: DocID: 1rn7P - View Document